EFFICACY OF IMMUNOSUPPRESSIVE DRUGS IN ISLET XENOTRANSPLANTATION
- 15 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (9) , 1234-1242
- https://doi.org/10.1097/00007890-199705150-00008
Abstract
Background. Morphological characteristics of islet xenograft rejection differ from those of islet allograft rejection. Therefore, prevention of islet xenograft rejection probably requires a different type of immunosuppression from that used in allogeneic transplantation. Methods. Fetal porcine islet-like cell clusters (ICC) were transplanted into the renal subcapsular space of rats treated with different immunosuppressive protocols. The existence of a cellular infiltrate or deposits of antibodies and complement in the grafts was evaluated at different times after transplantation using immunohistochemistry. Results. Treatment with leflunomide (LEF), cyclosporine (CsA), mycophenolate mofetil (MMF), 15-deoxyspergualin, and rapamycin alone or in combination had an insufficient inhibitory effect on ICC xenograft rejection. However, in animals treated with LEF+CsA, the rejection process was markedly inhibited. However, some macrophages and T cells were still present, and at 24 days, the xenografts were destroyed. In LEF+CsA-treated animals that were given sera containing an excessive amount of rat anti-porcine xenoreactive antibodies, marked deposits of IgG, and to some extent C3 as well, were detected along the border between intact ICC, and the xenografts were surrounded by macrophages. However, almost no cells infiltrated the grafts, and there were many intact ICC. In animals treated with LEF+CsA+MMF, only occasional infiltrating cells were seen at 12 and 24 days after transplantation, and the endocrine tissue was completely intact. Conclusions. LEF+CsA+MMF prevented rejection of porcine ICC xenografts in the rat for up to 24 days after transplantation.Keywords
This publication has 21 references indexed in Scilit:
- Prolongation of lung xenograft survival in rats with a short course of deoxyspergualin and cyclosporin ATransplant International, 1996
- REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1Transplantation, 1996
- THE MAIN INFILTRATING CELL IN XENOGRAFT REJECTION IS A CD4+ MACROPHAGE AND NOT A T LYMPHOCYTETransplantation, 1995
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- THE IMMUNOMODULATORY EFFECT OF LEFLUNOMIDE IN RAT CARDIAC ALLOTRANSPLANTATIONTransplantation, 1995
- Newer immunosuppressive drugs in concordant xenografting-Transplantation of hamster heart to ratXenotransplantation, 1994
- LEFLUNOMIDE CONTROLS REJECTION IN HAMSTER TO RAT CARDIAC XENOGRAFTSTransplantation, 1994
- Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet cell clustersXenotransplantation, 1994
- AN EVALUATION OF LEFLUNOMIDE IN THE CANINE RENAL TRANSPLANTATION MODEL1Transplantation, 1994
- LEFLUNOMIDE IN EXPERIMENTAL TRANSPLANTATIONTransplantation, 1994